The Catalan president receives a medical discharge after suffering an episode of pubic osteomyelitis
at the Palau de la Generalitat after receiving a medical discharge from the Vall d’Hebron hospital team in Barcelona, which has been treating her. Illa has suffered from pubic osteomyelitis and has been on sick leave since last January 16 when she was admitted to the Intensive Care Unit (ICU). The doctors discharged him two weeks ago and since then he has been undergoing treatment at his home in La Roca del Vallès.
The statement issued by the hospital this afternoon states that the Catalan president is progressing “very favorably” despite the fact that he will continue with antibiotic treatment. “He has fully recovered his mobility, which allows his progressive reincorporation.” In a message on the X network, Illa said that she will return to work on Monday.
Illa was receiving intravenous antibiotic treatment and the turning point in her recovery centered on when she could receive it orally. According to sources at the Vall d’Hebron hospital, during the Presidency, Illa has evolved very favourably.
Your subscription is being used on another device
Do you want to add another user to your subscription?
If you continue reading on this device, it will not be able to be read on the other.
Arrow
Your subscription is being used on another device and you can only access EL PAÍS from one device at a time.
If you want to share your account, change your subscription to Premium mode, so you can add another user. Each one will log in with their own email account, which will allow you to personalize your experience in EL PAÍS.
Do you have a business subscription? Go here to sign up for more accounts.
If you do not know who is using your account, we recommend changing your password here.
If you decide to continue sharing your account, this message will appear on your device and the device of the other person who is using your account indefinitely, affecting your reading experience. You can consult the terms and conditions of the digital subscription here.
